Toshiaki Onitsuka

Affiliations: 
2009-2011 Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Clinical Neuroscience Division, Laboratory of Neuroscience Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States 
 2012- Kyushu University and Kyushu Hospital, Fukuoika, Japan 
Google:
"Toshiaki Onitsuka"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Martha Elizabeth Shenton post-doc 2000-2003 Harvard Medical School - Brigham and Women's Hospital
 (Visiting Instructor at the PNL, HMS, Boston. Visiting Scholars Program, supported through funds from Kyushu University Medical School and by NIH funds.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ochi S, Tagata H, Hasegawa N, et al. (2022) Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other concomitant psychotropics: A real-world nationwide study. The International Journal of Neuropsychopharmacology
Muraoka H, Kodaka F, Hasegawa N, et al. (2022) Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study. Asian Journal of Psychiatry. 74: 103174
Hori H, Yasui-Furukori N, Hasegawa N, et al. (2022) Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics. Frontiers in Psychiatry. 13: 823826
Onitsuka T, Hirano Y, Nakazawa T, et al. (2022) Toward recovery in schizophrenia: Current concepts, findings, and future research directions. Psychiatry and Clinical Neurosciences
Furihata R, Otsuki R, Hasegawa N, et al. (2021) Hypotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study. Sleep Medicine. 89: 23-30
Yasui-Furukori N, Muraoka H, Hasegawa N, et al. (2021) Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study. Neuropsychopharmacology Reports
Numata S, Nakataki M, Hasegawa N, et al. (2021) Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study. Neuropsychopharmacology Reports
Sato J, Hirano Y, Hirakawa N, et al. (2021) Lower Hippocampal Volume in Patients with Schizophrenia and Bipolar Disorder: A Quantitative MRI Study. Journal of Personalized Medicine. 11
Ohara N, Hirano Y, Oribe N, et al. (2020) Neurophysiological Face Processing Deficits in Patients With Chronic Schizophrenia: An MEG Study. Frontiers in Psychiatry. 11: 554844
Ichihashi K, Hori H, Hasegawa N, et al. (2020) Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project. Neuropsychopharmacology Reports
See more...